Medical Assistant

Sanjeev K. Mahanta

** ********** **.. ************, ** 01772 . 508-***-**** .

**********@*****.***

EDUCATION

New England School of Law

Boston, MA

Candidate for Juris Doctor

May

2011

Activities: Member, Student Intellectual Property Law Association

2009-2010

Indian Institute of Science, Bangalore, India

Ph.D. in Biochemistry

1992

Gauhati University, Assam, India

M.Sc. in Chemistry - Equivalent to Bachelors in Science

1986

Admission

Registered to practice before the United States Patent and Trademark Office

April 2009

PROFESSIONAL EXPERIENCE

Minerva Biotechnologies Corporation

Waltham, MA

Group Leader Biology/Senior Scientist

July 2001 - Present

. Led drug discovery research in areas of Cancer, Neurodegenerative

diseases,

Stem cell growth and Gold Nanoparticle enhanced detection

methods.

New York University Medical Center

New York, NY Assistant

Research Scientist

Nov. 1997 - July 2001

. Carried out immunology research in the area of T lymphocyte

development.

Harvard University

Cambridge, MA

Post doctoral fellow

Sept. 1992-Nov.

1997

. Carried out research to understand molecular basis of a genetic defect

that

causes the immunodeficiency disease called "Bare Lymphocyte

Syndrome."

SCIENTIFIC EXPERIENCE

Biochemistry, Molecular Biology, Molecular Immunology, Transgenic mice

technology, Antibody engineering, Cancer biology, Compound screening,

Nanoparticle enhanced detection and Stem Cell growth enhancement

Fellowships and Awards

. University Grants Commission's (UGC) Ph.D. Fellowship (India, 1986)

. Fellowship of the Irvington Institute of Medical Research (New York,

1992)

PATENT RELATED EXPERIENCE

Minerva Biotechnologies Corporation

Waltham, MA

Group Leader Biology/Senior Scientist

Sept. 2009 - Present

. Specification writing: definitions and real and prophetic examples.

. Prosecution support: claim amendment, responding to prior art

rejections and other simple notices, submission of IDS, preparation

and submission post issue of document for the file history.

Malhotra Law Firm

Spokane, Washington

Intern

Dec. 2009 -

March 2010

. Litigation support: Assisted with an enforcement action of a patent

against infringement

China Pharma Hub Corp.

Cambridge, MA

Consultant

Jan. 2010

- Present

. Technology Licensing: Assisted with examining licensing agreements

between research institutes and a Biotechnology Company as part of due

diligence inquiry.

References:

Jack L Strominger, Higgins Professor of Biochemistry

Dept. of Molecular and Cellular Biology, Harvard University

617-***-**** *******@***.*******.***

Eileen M. Herhily

Associate Professor of Law

New England Law Boston

617-***-**** ********@****.***

Selected Patent and Publications

1. US Utility Patent Application titled, MUC1 Antibodies, Filed October

2009.

Inventors: Sanjeev K Mahanta and Cynthia Bamdad

2. MUC1* is a determinant of Herceptin resistance in breast cancer cells.

Fessler SP,

Wotkowicz, M, Mahanta SK, Bamdad C. Breast Cancer Research and

Treatment . 2009 Nov;118(1):113-24

3. Mahanta S, Fessler SP, Park J, Bamdad C. A minimal fragment of MUC1

mediates

growth of cancer cells. PLoS ONE. 2008 Apr 30;3(4):e2054.

4. Arockia Jeyaprakash, A, Jayashree, G, Mahanta, SK, Swaminathan, CP

Sekar, K

Surolia, A and Vijayan, M. Structural basis for the energetics of

jacalin-sugar

interactions: promiscuity versus specificity Journal of Molecular

Biology 2005 March

18; 347: 181-188

5. Guo, J, Hawari, A, Li, H., Sun, Z, Mahanta SK, Littman D R., Krangel,

M.S.,and e.

Y. -W. Regulation of the TCR? repertoire by the survival window of

CD4+CD8+

thymocytes. Nature Immunology. 2002 May 3;(5): 469-76

6. Mahanta SK, Scholl T, Yang FC, Strominger JL. Transactivation by CIITA,

the type

II bare lymphocyte syndrome -associated factor, requires participation

of multiple

regions of the TATA box binding protein. Proc Natl Acad Sci USA. 1997

Jun

10;94(12):6324-9

7. Scholl T*, Mahanta SK*, Strominger JL. Specific complex formation

between the

type II bare lymphocyte syndrome-associated transactivators CIITA and

RFX5. Proc

Natl Acad Sci USA. 1997 Jun 10;94(12)6330-4

8. Scholl T, Stevens MB, Mahanta S, Strominger JL A zinc finger protein

that represses

transcription of the human MHC class II gene, DPA. J Immunol. 1996 Feb

15; 156(4):

1448-57

9. Banerjee R, Mande SC, Ganesh V, Das K, Dhanaraj V, Mahanta SK, Suguna K,

Surolia A, Vijayan M. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):227-

31.

* Equal contribution

Membership in Associations

Boston patent Law Association

Visa status: Permanent resident and authorized to work in the

United States

Contact this candidate